Cerity Partners’s Mesa Laboratories MLAB Stock Holding History

Cerity Partners’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$772K	Sell	5,940 -1,473	-20%	-$167K	﹤0.01%	2187
2026 Q2	$738K	Buy	7,413 +168	+2%	+$16.9K	﹤0.01%	2185
2026 Q1	$641K	Buy	7,245 +3,884	+116%	+$335K	﹤0.01%	2130
2025 Q4	$264K	Buy	+3,361	New	+$256K	﹤0.01%	2483
2023 Q2	–	Sell	-95	Closed	-$1.01M	–	1840
2023 Q1	$1.01M	Buy	+95	New	+$17K	﹤0.01%	968
2018 Q2	–	Sell	-5,725	Closed	-$850K	–	568
2018 Q1	$850K	Hold	5,725	–	–	0.07%	254
2017 Q4	$712K	Hold	5,725	–	–	0.05%	278
2017 Q3	$855K	Hold	5,725	–	–	0.06%	251
2017 Q2	$820K	Hold	5,725	–	–	0.07%	188
2017 Q1	$702K	Buy	+5,725	New	+$701K	0.06%	222

Other funds holding MLAB

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $5.31B AUM 40.5% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Cerity Partners's MLAB Position: Q3 2026 in Review

Cerity Partners reduced its Mesa Laboratories (MLAB) stake by 20% in Q3 2026, selling an estimated $167K and leaving 5,940 shares worth $772K. The position accounts for ﹤0.01% of the portfolio, ranked #2187.

Cerity Partners first reported a position in MLAB in Q1 2017 and has held it in 10 quarters since. The position peaked at $1.01M in Q1 2023. 133 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

Cerity Partners held 5,940 shares of Mesa Laboratories worth $772K as of Q3 2026.
Cerity Partners sold 1,473 Mesa Laboratories shares in Q3 2026, an estimated $167K.
Mesa Laboratories made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #2187 holding.
Cerity Partners first reported a position in Mesa Laboratories in Q1 2017 and has held it in 10 quarters since.
Cerity Partners's Mesa Laboratories position peaked at $1.01M in Q1 2023.
133 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.